Hunan Sailong Pharmaceutical (Changsha) Co., Ltd.

Sailong Pharmaceutical was founded in 2002 and is a high-tech enterprise integrating pharmaceutical R&D, production, marketing, and technical services. On September 12, 2017, the company was successfully listed on the SME Board of the Shenzhen Stock Exchange (stock code: 002898). Currently, Sailong Pharmaceutical has six wholly-owned subsidiaries in Changsha and Yueyang, and two branches: the Sailong Pharmaceutical R&D Center and the Marketing Center. Sailong Pharmaceutical is committed to providing "safe, effective, and accessible" medicines to society. It now has a portfolio of nervous system drugs such as monosialotetrahexosylganglioside sodium API and preparations, and cerebroprotein hydrolysate for injection, as well as a number of therapeutic drugs with high clinical value, including parecoxib sodium for injection, tigecycline for injection, argatroban injection, ornithine aspartate injection, and dexlansoprazole for injection. The application of its drugs covers cardiovascular and cerebrovascular drugs, nervous system drugs, digestive system drugs, geriatric drugs, and other fields. It has now moved into the field of high-end dosage forms such as big health products, solid oral preparations, and sustained-release preparations. The company closely grasps the pulse of industry development and focuses on technological innovation and new drug R&D. The company has a R&D center with first-class hardware facilities, equipped with a set of large-scale precision instruments recommended by the US FDA and recognized by international pharmaceutical R&D institutions. It has gradually established scientific research platforms such as "chiral drugs," "sustained-release drugs," and "biochemical drugs." The company has built modern production lines for powder injections, freeze-dried powder injections, small-volume injections, biochemical APIs, and chemical synthetic APIs with advanced facilities, and has a full set of modern production and testing equipment. All have passed GMP certification at a high standard in one go and have continuously obtained high-tech enterprise recognition. Based in Zhuhai and looking across the country, the company's products sell well in 30 provinces, cities, and autonomous regions. With high-standard quality assurance, continuously upgraded products, marketing strategies that keep up with the market, and good and complete after-sales service, the company has frequently reported good results and achieved good economic and social benefits. Looking to the future, the company will continue to uphold its corporate purpose of "leading with technology, achieving health undertakings" and practice its corporate culture of "unity, hard work, dedication, and contribution." Walking on the fast track of technological innovation, Sailong Pharmaceutical sincerely invites new forces to join and create a century-old Sailong great cause! Benefits: 1. Listed company with a good platform. 2. Social insurance and housing fund are purchased upon onboarding, commercial insurance, and the housing fund is paid based on salary standards. 3. Year-end bonus and project bonus. 4. Holiday gifts or presents, birthday gift money, wedding gift money, and maternity gift money. 5. Good office environment; hotel-style cafeteria, buffet breakfast, two meat and two vegetable dishes plus soup for lunch and dinner, fruit; good dormitory environment, spacious, single rooms, 4-person rooms, with independent bathrooms, equipped with personal wardrobes, desks, storage cabinets, air conditioning, WiFi, and 24-hour hot water. 6. Good leaders with a broad vision who consider team members, and a harmonious team atmosphere. 7. Enjoy statutory holidays, paid leave (marriage leave, maternity leave, paternity leave, annual leave, bereavement leave), and two-day weekends (R&D has alternating big and small weekends). 8. Shuttle bus service, passing Metro Line 3.